Published: 6 April 2024
Author(s): Baeza-Herrera Luis Augusto, Ruíz-Beltrán Arturo Maximiliano, Alvarado-Alvarado José Alfredo, González-Pacheco Héctor
Issue: May 2024
Section: Letter to the Editor

Infective Endocarditis (IE) is a clinical entity with high morbidity and mortality despite advances in diagnosis and medical and surgical treatment alternatives. Globally, the prevalence is estimated to be approximately 1.5 cases per 100,000 people, with a mortality rate of 10–30 % [1]. The clinical outcomes of patients with IE exhibit considerable variability, mainly influenced by clinical, microbiological, and treatment characteristics. Heart Failure (HF) can complicate the evolution of patients with IE as a consequence of the structural valvular damage caused by vegetation and other associated lesions.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.